← Back to Clinical Trials
Recruiting NCT06836349

NCT06836349 Registry-randomized Comparison of Rehabilitation Regimens After Flexor Tendon Injury in the Thumb

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06836349
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Flexor Tendon Injury
Study Type INTERVENTIONAL
Enrollment 380 participants
Start Date 2025-05-01
Primary Completion 2031-12-31

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Early active motion training after operated FPL injuryImmobilisation in plaster cast 4 weeks after operated FPL injury

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 380 participants in total. It began in 2025-05-01 with a primary completion date of 2031-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Flexor tendon injuries in the thumb occur across all ages and genders. Each year, approximately 400 patients undergo surgery for a flexor tendon injury in Sweden. These injuries are exclusively treated at one of the seven specialized hand surgery clinics, as the surgery is technically demanding, and postoperative rehabilitation is critical, specialized, and requires expertise from hand therapists. To prevent tendon adhesions and stiffness in the thumb or fingers, controlled active motion therapy is usually initiated within a few days after surgery. Studies on finger flexor tendon injuries have shown that early active movement therapy leads to better mobility compared to immobilization. Consequently, early active training is now the standard treatment following flexor tendon repair. However, during postoperative rehabilitation, the repaired flexor tendon may rupture, often necessitating revision surgery. The rupture rate after flexor tendon repair in the thumb is approximately three times higher than in other fingers (10% vs. 3%). While most studies on flexor tendon injuries focus on finger tendons, research on the outcomes of thumb flexor tendon injuries is limited. The biomechanics and anatomy of the thumb's flexor tendon differ significantly from those of finger tendons. The objective of this study is to determine whether the rupture rate following thumb flexor tendon surgery can be reduced by immobilizing the thumb in a cast for four weeks postoperatively, compared to standard early active motion therapy, without negatively affecting joint mobility and thumb strength. Additionally, the study will evaluate patient-reported outcomes one year post-surgery for both rehabilitation regimens (immobilization vs. mobilization). This study is a registry-randomized clinical trial (RRCT) involving five hand surgery clinics in Sweden. Data following randomization between the two rehabilitation protocols will be collected through follow-up in the Swedish National Hand Surgery Quality Registry (HAKIR).

Eligibility Criteria

Inclusion Criteria: Complete laceration of the thumb flexor tendon (Flexor Pollicis Longus; FPL) within zone 1 and 2. Age over 15 years. Minors (\<18 years) are considered to have sufficient maturity to understand the implications of the research. Swedish-speaking / able to understand spoken and written Swedish. Surgery performed within 14 days from the time of injury. Exclusion Criteria: Tendon injury with a defect requiring tendon grafting. Another complete tendon injury in the same hand. Extensive associated injuries, such as fracture, vascular injury with circulatory impairment, large skin defect, or preoperative signs of infection. Patient deemed unsuitable for early active motion therapy due to factors such as lack of cooperation, cognitive impairment, or substance abuse issues. Patient declines follow-up in the HAKIR quality registry. Wound infection making early active motion therapy inappropriate.

Contact & Investigator

Central Contact

Maria Wilcke, MD, Associate professor

✉ maria.wilcke@ki.se

📞 +46812362022

Frequently Asked Questions

Who can join the NCT06836349 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, studying Flexor Tendon Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06836349 currently recruiting?

Yes, NCT06836349 is actively recruiting participants. Contact the research team at maria.wilcke@ki.se for enrollment information.

Where is the NCT06836349 trial being conducted?

This trial is being conducted at Linköping, Sweden, Örebro, Sweden, Stockholm, Sweden, Umeå, Sweden and 1 additional location.

Who is sponsoring the NCT06836349 clinical trial?

NCT06836349 is sponsored by Karolinska Institutet. The trial plans to enroll 380 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology